Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
Immuno-trol & immuno-trol low cells unable to recover cd19 values using cyto-stat cd3 (igg1)-fitc/b4-rd1 6605015 cs b4-fitc pn 6603859 or cs b4-rd1 pn 6603846 when analyszed as per instructions.